MBP and neoplasm: At 4 weeks, the intensity in the saline group was increased by 26.92 ± 30.3-fold and in the Nexavar® group by 11.69 ± 10.0 fold, whereas in the MBP-11901 group it was decreased by 0.02 ± 0.0-fold, so that almost no tumor bioluminescence was measured (Figure 6A,B and Table S3).